News

The World Health Organization (WHO) set a goal in October 2021 to fully immunise 70% of each nation's population against COVID-19 by the end of June 2022. Many Covid-19 vaccination programmes in developing countries, especially in Sub-Saharan Africa, were...

A novel 3D printed methodology for extracting stem cells from bioreactors has been created by researchers at the University of Technology, Sydney, opening the door to the possibility of high-quality, mass-produced stem cells in Australia at a cheaper price. Due...

Novartis has committed to investing $250 million in research and development over the next five years in an effort to find a cure for malaria and other neglected tropical diseases (NTDs). CEO Vas Narasimhan remarked in a statement that...

In order to speed up research and development (R&D) for communicable diseases that disproportionately hurt lower-income nations, GSK plc announced a commitment of £1 billion over 10 years. This research will focus on novel and ground-breaking vaccines and medications to diagnose...

According to a story in the Welt Am Sonntag (WAS) newspaper, the launch of the vaccine developed by German pharmaceutical company BioNTech for the Omicron coronavirus type may be postponed because of a dispute with the regulator over the licencing...

We have come a long way when it comes to female contraception. From caps and diaphragms to implants and injections, the number of options presented to women are numerous and often complex.  However, with almost 45% of unmarried men...

The $39 billion acquisition of Alexion by AstraZeneca was accomplished less than a year ago. However, the main business is investing immediately in its subsidiary for rare diseases, particularly in Ireland. A couple of months after the acquisition was...